Shri Ssb Medicose (Opc) Profile
Key Indicators
- Authorised Capital ₹ 1.50 M
- Paid Up Capital ₹ 0.10 M
- Company Age 3 Year, 7 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 0.50 M
- Revenue Growth 158.43%
- Profit Growth 10.88%
- Ebitda -39523.76%
- Net Worth 22.52%
- Total Assets 74.02%
About Shri Ssb Medicose (Opc)
Shri Ssb Medicose (Opc) Private Limited (SSMOPL) is a Company incorporated in India on 07 June 2021 (Three years and seven months 25 days old ). Its registered office is in Kanpur Nagar, Uttar Pradesh, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹0.50 M.
Rashi Matani and Manish Matani serve as directors at the Company.
Company Details
-
Location
Kanpur Nagar, Uttar Pradesh, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24290UP2021OPC147005
-
Company No.
147005
-
Incorporation Date
07 Jun 2021
-
Date of AGM
-
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Kanpur
Industry
Who are the key members and board of directors at Shri Ssb Medicose (Opc)?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rashi Matani
|
Director | 30-Jun-2021 | Current |
|
Manish Matani
|
Director | 07-Jun-2021 | Current |
Financial Performance of Shri Ssb Medicose (Opc).
Shri Ssb Medicose (Opc) Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 158.43% increase. The company also saw a substantial improvement in profitability, with a 10.88% increase in profit. The company's net worth Soared by an impressive increase of 22.52%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Shri Ssb Medicose (Opc)?
Unlock access to Shri Ssb Medicose (Opc)'s control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
₹0.50 M
₹0
Charges Breakdown by Lending Institutions
- Others : 0.05 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 21 Jun 2022 | Others | ₹0.50 M | Open |
How Many Employees Work at Shri Ssb Medicose (Opc)?
Shri Ssb Medicose (Opc) has a workforce of 0 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Shri Ssb Medicose (Opc), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Shri Ssb Medicose (Opc)'s trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.